Mannkind (MNKD) EPS (Weighted Average and Diluted) Growth (3y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -25,782.97% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 41.33% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.33% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1.99% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 45.47% |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn | -7.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.72% |
| Dec 31, 2025 | 10.61% |
| Sep 30, 2025 | 35.72% |
| Jun 30, 2025 | 26.40% |
| Mar 31, 2025 | 33.89% |
| Dec 31, 2024 | 31.48% |
| Sep 30, 2024 | 58.74% |
| Jun 30, 2024 | 58.51% |
| Dec 31, 2023 | 27.74% |
| Dec 31, 2021 | -22.39% |
| Sep 30, 2021 | 50.00% |
| Jun 30, 2021 | 4.35% |
| Dec 31, 2020 | 24.89% |
| Dec 31, 2018 | 75.94% |
| Sep 30, 2018 | -25.99% |